Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness

December 1, 2023 updated by: Vehniah Tjong, Northwestern University

Does the Addition of a Traction Pad Reduce the Rate of Postoperative Pudendal Neuralgia?

Compared to the knee and shoulder, the hip joint leaves relatively little space to maneuver arthroscopic instruments and camera. To expand the potential space in the hip joint, traction is commonly applied to the operative leg through a perineal post. This is an effective technique to improve the working space for arthroscopy, however it has been associated with complications, including perineal numbness. Traction pads, used alone or with a perineal post, can reduce pressure on the perineal area, thus reducing numbness. The investigators hypothesize that positioning hip arthroscopy patients using a traction pad on a standard traction table with a perineal post will reduce the incidence and duration of postoperative perineal numbness.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Northwestern University Department of Orthopaedic Surgery
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 88 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All patients presenting to Northwestern Memorial Hospital (NMH) or to a Northwestern orthopaedic surgery faculty member's clinic undergoing hip arthroscopy
  • Ability to read and speak English

Exclusion Criteria:

  • Revision surgery
  • Oncologic surgery
  • Use of regional anesthesia
  • Arthroscopic hip surgery that involves procedures other than labral repair, acetabuloplasty, CAM-plasty, IT band windowing, Iliopsoas lengthening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pink Pad
Hip arthroscopy using The Pink Pad Hip Kit Patient Positioning System (Xodus Medical, New Kensington, PA). The pad is placed between the patient and the traction table, using a perineal post.
The pad is placed between the patient and the traction table to reduce pressure to the pudendal nerve exerted by the perineal post.
Other Names:
  • Xodus Medical
No Intervention: Control (No pad)
Hip arthroscopy in the usual fashion, no pad, using traction table with perineal post.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient-reported post-operative numbness
Time Frame: Baseline prior to surgery
Y/N Are you experiencing complete or partial numbness prior to your surgery?
Baseline prior to surgery
patient-reported post-operative numbness
Time Frame: 72 hours after surgery
Y/N Are you experiencing complete or partial numbness as a result of your surgery?
72 hours after surgery
patient-reported numbness
Time Frame: 1 week after surgery
Y/N Are you experiencing complete or partial numbness as a result of your surgery?
1 week after surgery
patient-reported numbness
Time Frame: 3 weeks after surgery
Y/N Are you experiencing complete or partial numbness as a result of your surgery?
3 weeks after surgery
patient-reported numbness
Time Frame: 6 weeks after surgery
Y/N Are you experiencing complete or partial numbness as a result of your surgery?
6 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient-reported difficulty urinating
Time Frame: Baseline prior to surgery
Y/N Have you experienced difficulty urinating?
Baseline prior to surgery
patient-reported difficulty urinating
Time Frame: 72 hours after surgery
Y/N Have you experienced difficulty urinating?
72 hours after surgery
patient-reported difficulty urinating
Time Frame: 1 week after surgery
Y/N Have you experienced difficulty urinating?
1 week after surgery
patient-reported difficulty urinating
Time Frame: 3 weeks after surgery
Y/N Have you experienced difficulty urinating?
3 weeks after surgery
patient-reported difficulty urinating
Time Frame: 6 weeks after surgery
Y/N Have you experienced difficulty urinating?
6 weeks after surgery
patient-reported difficulty with bowel movements
Time Frame: Baseline prior to surgery
Y/N Have you experienced difficulty with bowel movements?
Baseline prior to surgery
patient-reported difficulty with bowel movements
Time Frame: 72 hours after surgery
Y/N Have you experienced difficulty with bowel movements?
72 hours after surgery
patient-reported difficulty with bowel movements
Time Frame: 1 week after surgery
Y/N Have you experienced difficulty with bowel movements?
1 week after surgery
patient-reported difficulty with bowel movements
Time Frame: 3 weeks after surgery
Y/N Have you experienced difficulty with bowel movements?
3 weeks after surgery
patient-reported difficulty with bowel movements
Time Frame: 6 weeks after surgery
Y/N Have you experienced difficulty with bowel movements?
6 weeks after surgery
patient-reported skin changes or breakdown
Time Frame: Baseline prior to surgery
Y/N Have you experienced skin changes or skin breakdown?
Baseline prior to surgery
patient-reported skin changes or breakdown
Time Frame: 72 hours after surgery
Y/N Have you experienced skin changes or skin breakdown?
72 hours after surgery
patient-reported skin changes or breakdown
Time Frame: 1 week after surgery
Y/N Have you experienced skin changes or skin breakdown?
1 week after surgery
patient-reported skin changes or breakdown
Time Frame: 3 weeks after surgery
Y/N Have you experienced skin changes or skin breakdown?
3 weeks after surgery
patient-reported skin changes or breakdown
Time Frame: 6 weeks after surgery
Y/N Have you experienced skin changes or skin breakdown?
6 weeks after surgery
patient-reported sexual disfunction or erectile disfunction
Time Frame: Baseline prior to surgery
Y/N Have you experienced sexual dysfunction/erectile dysfunction?
Baseline prior to surgery
patient-reported sexual disfunction or erectile disfunction
Time Frame: 72 hours after surgery
Y/N Have you experienced sexual dysfunction/erectile dysfunction?
72 hours after surgery
patient-reported sexual disfunction or erectile disfunction
Time Frame: 1 week after surgery
Y/N Have you experienced sexual dysfunction/erectile dysfunction?
1 week after surgery
patient-reported sexual disfunction or erectile disfunction
Time Frame: 3 weeks after surgery
Y/N Have you experienced sexual dysfunction/erectile dysfunction?
3 weeks after surgery
patient-reported sexual disfunction or erectile disfunction
Time Frame: 6 weeks after surgery
Y/N Have you experienced sexual dysfunction/erectile dysfunction?
6 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vehniah K Tjong, MD, Northwestern University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2021

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

September 1, 2021

First Submitted That Met QC Criteria

September 1, 2021

First Posted (Actual)

September 9, 2021

Study Record Updates

Last Update Posted (Estimated)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 1, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Injuries

Clinical Trials on The Pink Pad Hip Kit

3
Subscribe